(Q40612645)

22 September 2017

title

Enhanced expression of MYCN leads to centrosome hyperamplification after DNA damage in neuroblastoma cells (English)

1 reference

22 September 2017

0 references

1 reference

Eiji Sugihara

1

1 reference

22 September 2017

Masayuki Kanai

2

1 reference

22 September 2017

Akira Matsui

3

1 reference

22 September 2017

Masafumi Onodera

4

1 reference

22 September 2017

Manfred Schwab

5

1 reference

22 September 2017

Masanao Miwa

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

22 September 2017

1 reference

22 September 2017

volume

23

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

1005-1009

1 reference

Re-evaluating centrosome function

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

MAPK mediates RAS-induced chromosome instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

Suppression of MYC by high expression of NMYC in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Introduction. Centrosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Abnormal centrosome amplification in the absence of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl)ation in regulation of centrosome function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Micronuclei: a biological indicator of radiation damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

A possible role for centrosome overduplication in radiation-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Amplification of oncogenes revisited: from expression profiling to clinical application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Neuroblastoma: biology and molecular and chromosomal pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Loss of p53 and centrosome hyperamplification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Enhanced flexibility and aphidicolin-induced DNA breaks near mammalian replication origins: implications for replicon mapping and chromosome fragility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Genetic parameters of neuroblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207216

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207216

1 reference

Dimensions Publication ID

22 September 2017

1034027906

0 references

1 reference